Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease

CompletedOBSERVATIONAL
Enrollment

184

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 9, 2018

Study Completion Date

April 9, 2018

Conditions
Peyronie's Disease
Interventions
DRUG

Subjects Previously Treated with AA4500

no treatment to be administered - observational only

Trial Locations (30)

10016

Manhattan Medical Research Practice PLLC, New York

10577

Michael A. Werner, MD PC, Purchase

11021

Bruce R. Gilbert, MD, PhD, PC, Great Neck

12208

Community Care Physicians, PC, Albany

19004

Urologic Consultants of SE PA, Bala-Cynwyd

21061

Chesapeake Urology Research Associates, Glen Burnie

21204

Chesapeake Urology Research Associates, Towson

23235

Virginia Urology, Richmond

23462

Urology of Virginia, PLLC, Virginia Beach

27612

Associated Urologists of North Carolina, Raleigh

32803

Florida Urology Associates, Orlando

33180

South Florida Medical Research, Aventura

33449

Georgis Patsias, M.D., PA, Wellington

45212

Tristate Urologic Services dba TUG Research, Cincinnati

46123

Urology of Indiana LLC, Avon

47130

Metropolitan Urology P.S.C, Jefferson

60190

Dupage Medical Group, Winfield

60612

Uropartners, LLC, Chicago

66211

Kansas City Urology Care, PA, Overland Park

75231

Urology Clinics of North Texas, PA, Dallas

80211

The Urology Center of Colorado, Denver

83642

Idaho Urologic Institute, Meridian

84124

Jean Brown Research, Salt Lake City

91505

Urology Assoc Medical Group, Burbank

92120

San Diego Sexual Medicine, San Diego

92653

South Orange County Med Research Center, Laguna Hills

99503

Alaska Clinical Research Center, LLC, Anchorage

02467

Men's Health Boston, Chestnut Hill

07601

Center for Male Reproductive Medicine, Hackensack

08648

Premier Urology Assoc LLC dba AdvanceMed Research, Lawrenceville

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY